Literature DB >> 35212573

Impact of Sleep Disturbance, Physical Function, Depression and Anxiety on Male Lower Urinary Tract Symptoms: Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).

Alexander P Glaser1, Sarah Mansfield2, Abigail R Smith2, Brian T Helfand1, H Henry Lai3, Aruna Sarma4, Claire C Yang5, Michelle Taddeo6, J Quentin Clemens4,7, Anne P Cameron4, Kathryn E Flynn8, Victor Andreev2, Matthew O Fraser9, Bradley A Erickson10, Ziya Kirkali11, James W Griffith6.   

Abstract

PURPOSE: The impact of nonurological factors on male lower urinary tract symptoms (LUTS) remains unclear. We investigated cross-sectional and longitudinal associations among anxiety, depression, physical function, sleep quality and urinary symptom subdomains.
MATERIALS AND METHODS: Data from 518 men in the LURN (Symptoms of Lower Urinary Tract Dysfunction Research Network) study were analyzed to identify associations between Patient-Reported Outcomes Measurement Information System® (PROMIS®) depression, anxiety, sleep disturbance and physical function measures and LUTS subdomains, as derived from the American Urological Association Symptom Index and LUTS Tool. Multivariable linear regression was used to assess the relationships between PROMIS measures and LUTS subdomains at baseline and at 3- and 12-month followup.
RESULTS: Baseline depression and anxiety were associated with urinary incontinence (p <0.001), voiding symptoms (p <0.001) and quality of life (p=0.002), whereas baseline sleep disturbance was associated with voiding and storage symptoms and quality of life (p <0.001 for all). Urinary symptom severity improved in all subdomains at 3 and 12 months. Similar associations between PROMIS measures and LUTS subdomains were observed at all time points, but baseline depression, anxiety, sleep disturbance and physical function measures were not associated with longitudinal trajectories of LUTS.
CONCLUSIONS: Urinary symptom subdomains are independently associated with modifiable clinical variables including sleep quality and depression at all time points, but these variables do not predict the degree of improvement in LUTS following urological evaluation and treatment over the medium term. Bidirectional assessment and randomized experiments may improve our understanding of these relationships.

Entities:  

Keywords:  anxiety; depression; lower urinary tract symptoms; patient reported outcome measures; quality of life

Mesh:

Year:  2022        PMID: 35212573      PMCID: PMC9336513          DOI: 10.1097/JU.0000000000002493

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.600


  27 in total

1.  A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire.

Authors:  David Cella; Abigail R Smith; James W Griffith; Kathryn E Flynn; Catherine S Bradley; Brenda W Gillespie; Ziya Kirkali; Pooja Talaty; J Eric Jelovsek; Brian T Helfand; Kevin P Weinfurt
Journal:  Neurourol Urodyn       Date:  2019-06-21       Impact factor: 2.696

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10.

Authors:  David Cella; Abigail R Smith; James W Griffith; Ziya Kirkali; Kathryn E Flynn; Catherine S Bradley; J Eric Jelovsek; Brenda W Gillespie; Brian T Helfand; Pooja Talaty; Kevin P Weinfurt
Journal:  J Urol       Date:  2019-07-31       Impact factor: 7.450

Review 4.  The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction.

Authors:  Carlos D'Ancona; Bernard Haylen; Matthias Oelke; Luis Abranches-Monteiro; Edwin Arnold; Howard Goldman; Rizwan Hamid; Yukio Homma; Tom Marcelissen; Kevin Rademakers; Alexis Schizas; Ajay Singla; Irela Soto; Vincent Tse; Stefan de Wachter; Sender Herschorn
Journal:  Neurourol Urodyn       Date:  2019-01-25       Impact factor: 2.696

5.  Validity of PROMIS physical function measured in diverse clinical samples.

Authors:  Benjamin D Schalet; Ron D Hays; Sally E Jensen; Jennifer L Beaumont; James F Fries; David Cella
Journal:  J Clin Epidemiol       Date:  2016-03-09       Impact factor: 6.437

6.  Longitudinal Analysis of Bidirectional Relationships between Nocturia and Depressive Symptoms: The Nagahama Study.

Authors:  Satoshi Funada; Yasuharu Tabara; Hiromitsu Negoro; Shusuke Akamatsu; Takayuki Yoshino; Koji Yoshimura; Norio Watanabe; Toshiaki A Furukawa; Fumihiko Matsuda; Osamu Ogawa
Journal:  J Urol       Date:  2019-11-21       Impact factor: 7.450

7.  Risk factors for male lower urinary tract symptoms: the role of metabolic syndrome and androgenetic alopecia in a Latin American population.

Authors:  João Arthur B A Barbosa; Eduardo Muracca; Elcio Nakano; Mário Paranhos; Renato Natalino; Paulo Cordeiro; Miguel Srougi; Alberto Azoubel Antunes
Journal:  Urology       Date:  2013-05-01       Impact factor: 2.649

8.  The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.

Authors:  Karin S Coyne; Alan J Wein; Andrea Tubaro; Chris C Sexton; Christine L Thompson; Zoe S Kopp; Lalitha P Aiyer
Journal:  BJU Int       Date:  2009-04       Impact factor: 5.588

9.  Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer.

Authors:  Zaker Rana; Robert L Hong; Mustafa Abugideiri; Donald McRae; George Cernica; Robert Mordkin; Andrew B Joel; Gregory Bernstein; Nadim M Nasr
Journal:  Radiat Oncol       Date:  2015-08-28       Impact factor: 3.481

10.  Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson; Daniël M Jonker
Journal:  AAPS J       Date:  2020-07-29       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.